A Phase II Trial of Long‐Term Intravenous Treatment With Biweekly Azithromycin in Patients With Extranodal Marginal Zone B‐Cell‐Lymphoma of the Mucosa Associated Lymphoid Tissue— Maltiva
Hematological Oncology · 2026-11 · 44 (6)
DOI: 10.1002/hon.70293 ↗At a glance
Journal article in Hematological Oncology, published online on 2026-11-20. Written by Vincent Sunder‐Plassmann and 7 co-authors. 22 references.
Abstract (original language)
Není k dispozici žádný abstrakt.
Cite
APA
Sunder‐Plassmann, V., Kiesewetter, B., Lagler, H., Dolak, W., Mayerhoefer, M. E., Brand, R., Simonitsch‐Klupp, I., & Raderer, M. (2026). A Phase II Trial of Long‐Term Intravenous Treatment With Biweekly Azithromycin in Patients With Extranodal Marginal Zone B‐Cell‐Lymphoma of the Mucosa Associated Lymphoid Tissue— Maltiva. Hematological Oncology, 44(6). https://doi.org/10.1002/hon.70293
Vancouver
Sunder‐Plassmann V, Kiesewetter B, Lagler H, Dolak W, Mayerhoefer ME, Brand R, et al. A Phase II Trial of Long‐Term Intravenous Treatment With Biweekly Azithromycin in Patients With Extranodal Marginal Zone B‐Cell‐Lymphoma of the Mucosa Associated Lymphoid Tissue— Maltiva. Hematological Oncology. 2026;44(6). doi:10.1002/hon.70293
BibTeX
@article{SunderPlassmann2026,
author = {Sunder‐Plassmann, Vincent and Kiesewetter, Barbara and Lagler, Heimo and Dolak, Werner and Mayerhoefer, Marius E. and Brand, Rosa and Simonitsch‐Klupp, Ingrid and Raderer, Markus},
title = {A Phase II Trial of Long‐Term Intravenous Treatment With Biweekly Azithromycin in Patients With Extranodal Marginal Zone B‐Cell‐Lymphoma of the Mucosa Associated Lymphoid Tissue— Maltiva},
journal = {Hematological Oncology},
year = {2026},
volume = {44},
number = {6},
doi = {10.1002/hon.70293}
}
EUVIMED